Ferring And Blackstone Launch Gene Therapy Company
Set Up To Market Nadofaragene Firadenovec For Bladder Cancer
The Swiss group has decided to launch FerGene with the private equity giant to give the gene therapy nadofaragene firadenovec, which has a priority review at the FDA, a better chance for a successful launch in the US.
